Abstract

Amyloidoses are a group of diseases associated with the formation of pathological protein fibrils with cross-β structures. Approximately 5–10% of the cases of these diseases are determined by amyloidogenic mutations, as well as by transmission of infectious amyloids (prions) between organisms. The most common group of so-called sporadic amyloidoses is associated with abnormal aggregation of wild-type proteins. Some sporadic amyloidoses are known to be induced only against the background of certain pathologies, but in some cases the cause of amyloidosis is unclear. It is assumed that these diseases often occur by accident. Here we present facts and hypotheses about the association of sporadic amyloidoses with vascular pathologies, trauma, oxidative stress, cancer, metabolic diseases, chronic infections and COVID-19. Generalization of current data shows that all sporadic amyloidoses can be regarded as a secondary event occurring against the background of diseases provoking a cellular stress response. Various factors causing the stress response provoke protein overproduction, a local increase in the concentration or modifications, which contributes to amyloidogenesis. Progress in the treatment of vascular, metabolic and infectious diseases, as well as cancers, should lead to a significant reduction in the risk of sporadic amyloidoses.

Highlights

  • 90% of all cases of amyloid diseases belong to the group of sporadic amyloidoses

  • In the case of genetically determined amyloidoses, the pathology is associated with the occurrence of mutations that provoke amyloidogenesis

  • The data presented in this review indicate that sporadic amyloidoses can be regarded as a secondary event occurring against the background of diseases provoking a cellular stress response (Table 1) For the majority of proteins included in this group, it was shown that certain factors cause their overproduction, which promotes amyloidogenesis (Table 1)

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Pathological amyloid fibrils are formed as a result of protein misfolding, which can be provoked by various factors. Certain infectious properties have been shown for some other amyloid proteins, such as α-synuclein and tau [9,10,11,12], but the natural foodborne transmission is indicated only for PrPSc. The group of amyloidoses associated with mutations that promote protein aggregation is extensive. Mutations in several genes have been shown to contribute to the accumulation and aggregation of amyloid peptide beta (Aβ), which causes neurotoxicity in Alzheimer’s disease [14]. Some sporadic amyloidoses are known to be induced only against the background of certain pathologies, but in some cases the cause of amyloidosis is not so obvious.

Sporadic Alzheimer’s Disease and Tauopathies
Sporadic Parkinson’s and Prion Diseases
Sporadic Amyloidoses Localized Outside the CNS
Different Types of Cancer Cause Amyloidogenesis of Certain Proteins
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.